10.3390/biomedicines12081708 Summary Keywords aromatase inhibitors, dermatologic adverse events, FDA adverse event reporting system, disproportionality analysis, real-world Citation Wu Y-Y, Huang Q-L, Luo Z-Y, Song X-Y, Shi Y-Y, Zheng J-Z and Liu S (2025) Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
Atherosclerosis, inflammation and the accumulation of lipids in the inner layer of blood vessel walls lead to vascular blockage and contributes to the development of coronary heart disease, cerebrovascular disease and peripheral arterial vascular disease, and is associated with significant clinical morbidity and mortality rates (57)
Ro is also well-suited for people who value personalized, provider-led care
This effect can be a feature or a drawback depending on your goal
When the drug stops, the signal stops
Is the primary care system addressing the hard health issues in cardiac care